SLC9A6 and metabolic dysfunction-associated steatotic liver disease: Given that H4K16ac is a key player in type 2 diabetes and ageing, it will be worthwhile to further investigate whether SLC9A6‐126aa/H4K16ac affects NAFLD‐related diseases.50